Importantly, in these studies, investigators demonstrated that use of synthetic angiotensin II improved outcomes in patients with presumed AngII deficiency by elevated renin concentrations, including improved renal recovery [6, 10]. The gene discussed is AGT; the disease is hyperinsulinemic hypoglycemia, familial, 4.